GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroGen Inc (MEX:FGEN) » Definitions » Inventories, Finished Goods

FibroGen (MEX:FGEN) Inventories, Finished Goods : MXN90 Mil (As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is FibroGen Inventories, Finished Goods?

FibroGen's quarterly finished goods declined from Dec. 2023 (MXN95 Mil) to Mar. 2024 (MXN94 Mil) and declined from Mar. 2024 (MXN94 Mil) to Jun. 2024 (MXN90 Mil).

FibroGen's annual finished goods declined from Dec. 2021 (MXN167 Mil) to Dec. 2022 (MXN62 Mil) but then increased from Dec. 2022 (MXN62 Mil) to Dec. 2023 (MXN95 Mil).


FibroGen Inventories, Finished Goods Historical Data

The historical data trend for FibroGen's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroGen Inventories, Finished Goods Chart

FibroGen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 81.06 121.60 167.25 62.23 94.63

FibroGen Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 81.42 80.32 94.63 93.87 89.53

FibroGen Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.


FibroGen Business Description

Industry
Traded in Other Exchanges
Address
409 Illinois Street, San Francisco, CA, USA, 94158
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.